Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

View:
Post by dannyd9 on Mar 23, 2016 5:25pm

earnings

On an adjusted basis, CXR matched pretty well the lowest estimate on the street. On the revenue side, it crushed the average and low estimate. Going forward, will not have the many one time costs which affected eps this quarter and will have a full quarter of their most recent acquisition. Overall, an above average quarter. Think we will need to hear conference call to determine if mkt will bid it up based on next quarters estimate. Certainly, unlikely to soar based on these results, in my opinion.
Comment by stockguy2015 on Mar 23, 2016 5:42pm
Depends on what your meaning of soar is. I think we will jump up 5 or 6 dollars tomorrow easy and possibly a lot more. A lot of people were sitting on the sidelines waiting to see what was going on. There would be a fair amount of shorts that would have stayed in looking for brutal numbers aswell.
Comment by stockguy2015 on Mar 23, 2016 5:57pm
Year-over-year revenue growth of $289 million or an increase of 276 per cent Year-over-year adjusted EBITDA1 growth of $206 million or an increase of 347 per cent Reaffirms guidance2 of $1,020 million to $1,060 million in revenue and adjusted EBITDA1 of $610 million to $640 million These aren't just ok numbers they are a heck of a lot better than most expected after VRX's mess IMO
Comment by visionaryfool on Mar 23, 2016 6:02pm
I'd have to agree with DannyD9, they missed Q4 earnings by 8 cents USD but they beat full year earnings estimate of $4.35USD vs. actual of $4.38USD. The revenue crushed it and I think the big payoff will be in Q1 when they have NO acqusition costs. Might be deliberate from management to show the street that the Company is able to generate strong EPS if they stop having one time costs. I' ...more  
Comment by kender77 on Mar 23, 2016 6:23pm
I'm no fundamentalist but compared to Valeant's results, this should look might good to investors considering the extreme pessimism in the pharma sector. CEO bought at 45. Makes sense he did now.
Comment by denlep on Mar 23, 2016 6:11pm
Nothing new. Results pretty much in line with expectation and guidance reaffirmed like they did in a presentation in January et February and the presentation already on their website since a couple of weeks. I should reassure the most nervous investors but it is still a show me for some investors. Each new quarter should give confidance in their guidance. The worst is behind us but it will take ...more  
Comment by fep2009 on Mar 23, 2016 6:28pm
I agree with you on the share price I would think it will go back up to the 45.00 level that it was crusing at before everyone panicked over Vrx. This just shows Cxr is not Vrx let the good times roll glad I kept my shares. Regardless these health companies even Vrx aren't going anywheres anytime soon. 
Comment by fdfd12 on Mar 23, 2016 6:41pm
STOCKGUY, I see nothing in this report to jump $5 or $6 tomorrow. I see a nice steady gradual rise over time but not what you said.
Comment by stockguy2015 on Mar 23, 2016 6:49pm
We were trading at the 45 level last week before being brought down by the vrx stuff. My thinking is this report confirms they were on track at the 45 level plus they numbers were good. You have to remember there were a ton of people that bailed which will jump back on board and then we have the shorts that didn't cover and I know of a couple of them that were waiting for horrible news. I ...more  
Comment by Joseph_K on Mar 23, 2016 7:25pm
Nice spin.  You were trading at the $35 level as well last week.  Up $5 bucks now.  Guidance only reconfirmed for 2016 right?  So does that mean the results are already baked in to the current price? I still like it as a year long hold or for a bit of a run until a top turn takes place, but I'm not expecting a big move tomorrow.   If it gets to $45 tomorrow, I ...more  
Comment by Investor198 on Mar 23, 2016 6:50pm
This post has been removed in accordance with Community Policy
Comment by JustforFun7 on Mar 23, 2016 6:59pm
The shareprice of this stock is anything but steady. Where have you been the last 6 months?  I think the results are pretty much in line with what I thought they would be. Good revs, miss on earnngs consensus but not by a huge amount and for one time cost reasons.  Confirmed guidance is great but I think the company has a lot of wiggle room to do this so the market reaction will not be ...more  
Comment by fdfd12 on Mar 23, 2016 7:20pm
OK here we go again. Where is NUTWRONG. INVESOTOR198 is the only pumper we know. What do you see that there will be a jump of $5? They missed on earnings and they guided the same as they did before. What I am missing that is OUTSTANDING? It is a good Q for a stock trading at 4x. Time for it to trade 10X.
Comment by fdfd12 on Mar 24, 2016 9:44pm
Unfortunatly,  I rest my cas to you all.
Comment by Investor198 on Mar 24, 2016 10:02pm
Are you OK ?? I hope ur not drunk
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities